The LPL gene gives your body instructions to make lipoprotein lipase, an enzyme that breaks down triglycerides in fats carried through the blood after meals. If this gene does not work well, fat can build up in the bloodstream, which may lead to very high triglycerides and, in some people, belly pain or pancreatitis. This gene helps your body use fat for energy and storage, especially in muscle and fat tissue. Some variants in the LPL gene are linked to inherited high triglycerides, while others have little effect.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or direct activities in the body. Some genes hold the code for proteins, the working parts of cells. Others mainly regulate when certain processes happen, where they take place, and how strongly they run. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
LPLGene function
What if the gene works
The LPL gene helps break down fats in the blood after meals. This lets muscles use fat for energy and helps body tissues store extra fat.
Risk
What if the gene does not work
Changes in the LPL gene can raise blood fat levels. More severe variants often cause familial chylomicronemia syndrome, with recurrent pancreatitis, while milder variants may mainly increase triglycerides and cardiovascular risk.
Treatment
What does that mean for your treatment
Pathogenic variants in the LPL gene usually shift treatment toward a lifelong very low fat diet and avoiding alcohol, because standard triglyceride-lowering drugs often help less in complete LPL deficiency. Estrogen-containing medicines can worsen triglycerides, so alternatives may be preferred. In some people with familial chylomicronemia syndrome, APOC3-lowering treatment may also be considered.
Conditions associated with LPL
Gene function
What if the gene works
After you eat, your body needs a simple way to unpack fat from the bloodstream. Understanding how the LPL gene helps break down fats in the blood makes it easier to see how your body uses fat from food for fuel. Its protein sits on tiny blood vessel walls and releases usable fatty acids for nearby tissues.
The LPL gene helps split triglycerides, a main form of fat, into smaller fatty acids your cells can use. This happens as particles carrying fat travel through tiny blood vessels.
Muscles and the heart use these released fatty acids as a steady fuel source, especially between meals or during activity. This helps move energy from the blood into tissues that need it.
Body fat tissue can also take up some of these fatty acids and store them for later use. This supports normal energy balance and gives your body a reserve supply between meals.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help create normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some cases, however, a variant can change the function of a gene more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the LPL gene can change the shape of lipoprotein lipase, lower its activity, or stop it from reaching or attaching to the blood vessel lining, which slows triglyceride breakdown. Some LPL gene variants that affect triglyceride breakdown are mild and leave partial enzyme activity, while more severe variants can cause little or no activity. That difference often influences how early high triglyceride levels appear and how pronounced they become.
How variants are linked to conditions
Pathogenic variants in the LPL gene can cause familial chylomicronemia syndrome, a rare inherited condition with very high triglycerides that can trigger repeated pancreatitis. Many other LPL gene variants linked to high triglycerides have milder effects and are associated with a higher chance of mixed or familial hypertriglyceridemia. Some common changes are also associated with slightly different risks of coronary artery disease, but they do not determine your health on their own.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are widely seen across the general population. Most do not directly affect health and simply contribute to normal human variation. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a part. In contrast, a single well-studied variant in a particular gene can sometimes be enough to establish a diagnosis.
Are there things that can increase or change my risk?
For people with harmful changes in the LPL gene, risk is shaped less by lifestyle alone and more by how much triglycerides rise in the blood. High-fat eating, alcohol, uncontrolled diabetes, pregnancy, and some medicines can push triglycerides higher and raise the chance of painful pancreatitis attacks.
Inheritance of LPL variants
For families asking how LPL gene variants are inherited, the well-established pattern for LPL deficiency is autosomal recessive. This means a person usually inherits one altered copy of the LPL gene from each parent. When both parents carry one variant, each pregnancy has a 25% chance of an affected child, a 50% chance of a child who is a carrier, and a 25% chance of a child with two usual copies. Sons and daughters are affected at similar rates.
What does my LPL result mean for my family?
For LPL, family implications are usually discussed in the setting of a rare inherited condition that causes very high triglyceride levels. Parents of an affected child are often healthy carriers, and brothers or sisters may also be affected or may be carriers. Other close relatives may want to learn whether the change runs in the family, especially if there is a history of very high blood fat levels or pancreatitis.
Genetic information
Genetic testing
How you find out about variants
Variants in the LPL gene are found with a DNA test using blood, saliva, or a cheek swab. In LPL genetic testing for high triglycerides, the lab reads the gene to look for changes that may help confirm familial chylomicronemia syndrome or show a variant of uncertain significance.
When should I consider getting a genetic test?
Consider LPL genetic testing if you or your child has very high blood fat levels, repeated pancreatitis, or a strong family history of these problems. Testing can help confirm an inherited cause and may clarify whether close relatives could also be affected.
A genetic result is only one part of your health story
A genetic result can be very informative, but how much it explains depends on the condition and on the kind of variant involved. Over time, the way the body functions is shaped by many factors, including lifestyle, environment, age, and medical history. With some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help put a person’s experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles certain medicines, so the same treatment may work a little differently from one person to another. Some people process a drug more slowly, while others process it faster, which can change how much benefit they get or how likely they are to notice side effects. This kind of difference is common and helps explain why medication response is not exactly the same for everyone.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. By looking at connections between genes and drugs, it helps explain why the same treatment can work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support more informed and more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the LPL gene
When should I seek medical advice?
There is not yet a widely confirmed role for this gene in guiding medicine choice, so questions about treatment, side effects, or blood fat levels are best discussed with your doctor. Research on the LPL gene has looked at whether inherited changes may affect response to some medicines used to lower very high blood fat levels, but this is not strong enough to guide routine care.
History
Since the earliest days of medicine, efforts have been made to understand inherited patterns. In the mid 20th century, researchers studying unusually milky blood samples after meals uncovered clues that led to lipoprotein lipase, the enzyme made from the LPL gene. By the 1970s and 1980s, families with very high triglyceride levels helped show that inherited variants in the LPL gene could underlie a rare condition now called familial chylomicronemia. Building on this early work, scientists cloned and mapped the gene, which made genetic study much more precise. These discoveries also shaped modern understanding of inherited lipid conditions and helped connect blood fat patterns with specific genes. Over time, the LPL gene became a landmark in the history of cholesterol and triglyceride research.